Allotment of scrip shares

RNS Number : 1493E

The MedicX Fund Limited

01 April 2011

 



Press Release

For immediate release                                                                                    

1 April 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Chairman and Investment Adviser

David Staples (the Company's Chairman) and MedicX Adviser Ltd (the Company's Investment Adviser) elected to participate in the Company's scrip dividend scheme in respect of the March 2011 interim dividend for the quarter ended 31 December 2010, and accordingly were allotted 601 and 12,035 new ordinary shares of no par value in the Company (the "Shares") respectively.  The issue of these shares brings the total holding of the Chairman to 42,863 shares, and the total holding of the Investment Adviser to 646,002 shares.  The Shares were admitted to the Official List of the FSA and to trading on the Main Market of the London Stock Exchange on 31 March 2011 and rank pari passu with the Company's existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

End

For further information please contact:

MedicX Group                                                                 [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited                                          [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                              [phone]

Charles Ryland/Suzanne Brocks

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 58 properties.

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

 The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCLLFEFSIILIIL